Search Results - "Clemons, M.J"

Are Estring® and Vagifem® Equally Effective and Safe for the Treatment of Urogenital Atrophy in Breast Cancer Patients on Aromatase Inhibitor Therapy? by Simmons, C.E, Kuchuk, I, Freedman, O.C, Colgan, T, Dodd, A, Kulhanek, K, Sheiner, J, Dranitsaris, G, Dowsett, M, Folkerd, E, Clemons, M.J

Get full text

5027 A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and non-steroidal (anastrozole) aromatase inhibitors on biomarkers in post-menopausal women with hormone receptor positive locally advanced breast cancer (LABC) by Freedman, O, Amir, E, Dranitsaris, G, Dowsett, M, Cole, D.E.C, Hanna, W, O'Malley, F, Folkerd, E, Verma, S, Clemons, M.J

Get full text

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? by Simmons, C., Miller, N., Geddie, W., Gianfelice, D., Oldfield, M., Dranitsaris, G., Clemons, M.J.

“…Decisions about systemic treatment of women with metastatic breast cancer are often based on estrogen receptor (ER), progesterone receptor (PgR), and Her2…”
Get full text

Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines by Joy, A A, Ghosh, M, Fernandes, R, Clemons, M J

“…Despite advancements in the treatment of early-stage breast cancer, many patients still develop disease recurrence; others present with de novo metastatic…”
Get full text

i and fatal neutropen and fatal neutropenic enterocolitis following adjuvant chemotherapy for breast cancer by Clemons, M.J., Valle, J.W., Harris, M., Ellenbogen, S., Howell, A.

“…Neutropenic enterocolitis is increasingly being recognized as a life-threatening complication of chemotherapy, mainly for haematological and…”
Get full text

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group by Judson, I, Radford, J.A, Harris, M, Blay, J.-Y, van Hoesel, Q, le Cesne, A, van Oosterom, A.T, Clemons, M.J, Kamby, C, Hermans, C, Whittaker, J, Donato di Paola, E, Verweij, J, Nielsen, S

“…CAELYX®/DOXIL®, pegylated liposomal doxorubicin, has shown antitumour activity and reduced toxicity compared with standard doxorubicin in other tumour types…”
Get full text

Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer by Young, S D, Lafrenie, R M, Clemons, M J

“…This phase ii clinical trial examined the activity of a metronomic dosing schedule of docetaxel and capecitabine chemotherapy in patients with advanced breast…”
Get full text

Pre-menopausal breast cancer and aromatase inhibitors : treating a new generation of women by FREEDMAN, O. C, VERMA, S, CLEMONS, M. J

“…Aromatase inhibitors have revolutionized the treatment of post-menopausal women with hormone receptor positive breast cancer. However, approximately 22% of all…”
Get full text

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution? by Freedman, O.C., Verma, S., Clemons, M.J.

“…Despite improvements in the management of patients with early breast cancer, the prognosis for women with locally advanced breast cancer (LABC) remains poor…”
Get full text

Use and delivery of granulocyte colony-stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy-single-centre experience by Zhu, X, Bouganim, N, Vandermeer, L, Dent, S F, Dranitsaris, G, Clemons, M J

“…Use of granulocyte colony-stimulating factor (g-csf) as primary prophylaxis against chemotherapy-induced neutropenia has significant cost implications. We…”
Get full text

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma by Judson, I, Radford, J.A, Harris, M, Blay, J.-Y, van Hoesel, Q, le Cesne, A, van Oosterom, A.T, Clemons, M.J, Kamby, C, Hermans, C, Whittaker, J, Donato di Paola, E, Verweij, J, Nielsen, S

Get full text

0-30. Sexuality in women receiving chemotherapy for breast cancer by Clemons, M.J., Valle, J., Hayes, S., Fallowfield, L., Howell, A.

Get full text